200 related articles for article (PubMed ID: 18416937)
1. Optimizing delivery of flurbiprofen to the colon using a targeted prodrug approach.
Philip AK; Dubey RK; Pathak K
J Pharm Pharmacol; 2008 May; 60(5):607-13. PubMed ID: 18416937
[TBL] [Abstract][Full Text] [Related]
2. Optimized prodrug approach: a means for achieving enhanced anti-inflammatory potential in experimentally induced colitis.
Philip AK; Dabas S; Pathak K
J Drug Target; 2009 Apr; 17(3):235-41. PubMed ID: 19558362
[TBL] [Abstract][Full Text] [Related]
3. Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: synthesis, in vitro and in vivo assessment.
El-Kamel AH; Abdel-Aziz AA; Fatani AJ; El-Subbagh HI
Int J Pharm; 2008 Jun; 358(1-2):248-55. PubMed ID: 18502065
[TBL] [Abstract][Full Text] [Related]
4. Naproxen glycine conjugate-synthesis, pharmaceutical preformulation and pharmacodynamic evaluation.
Mishra A; Agrawal S; Pathak K
Drug Deliv; 2012 Feb; 19(2):102-11. PubMed ID: 22239596
[TBL] [Abstract][Full Text] [Related]
5. Pharmaceutical approaches to colon targeted drug delivery systems.
Chourasia MK; Jain SK
J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid for colon-specific drug delivery in inflammatory bowel disease.
Dhaneshwar SS; Kandpal M; Vadnerkar G; Rathi B; Kadam SS
Eur J Med Chem; 2007 Jun; 42(6):885-90. PubMed ID: 17258353
[TBL] [Abstract][Full Text] [Related]
7. Design and evaluation of colon specific drug delivery system containing flurbiprofen microsponges.
Orlu M; Cevher E; Araman A
Int J Pharm; 2006 Aug; 318(1-2):103-17. PubMed ID: 16687222
[TBL] [Abstract][Full Text] [Related]
8. Potential prodrugs of non-steroidal anti-inflammatory agents for targeted drug delivery to the CNS.
Perioli L; Ambrogi V; Bernardini C; Grandolini G; Ricci M; Giovagnoli S; Rossi C
Eur J Med Chem; 2004 Aug; 39(8):715-27. PubMed ID: 15276305
[TBL] [Abstract][Full Text] [Related]
9. Flurbiprofen-antioxidant mutual prodrugs as safer nonsteroidal anti-inflammatory drugs: synthesis, pharmacological investigation, and computational molecular modeling.
Ashraf Z; Alamgeer ; Kanwal M; Hassan M; Abdullah S; Waheed M; Ahsan H; Kim SJ
Drug Des Devel Ther; 2016; 10():2401-19. PubMed ID: 27555750
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine and glycine derivatives as potential prodrugs: design, synthesis, and pharmacological evaluation of amide derivatives of mefenamic acid.
Rasheed A; Ashok Kumar CK
J Enzyme Inhib Med Chem; 2010 Dec; 25(6):804-11. PubMed ID: 20578977
[TBL] [Abstract][Full Text] [Related]
11. Dextrans--potential polymeric drug carriers for flurbiprofen.
Shrivastava SK; Jain DK; Trivedi P
Pharmazie; 2003 Jun; 58(6):389-91. PubMed ID: 12857000
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis.
Jung Y; Kim HH; Kim H; Kong H; Choi B; Yang Y; Kim Y
Eur J Pharm Sci; 2006 May; 28(1-2):26-33. PubMed ID: 16455235
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological evaluation of some dual-acting amino-alcohol ester derivatives of flurbiprofen and 2-[1,1'-biphenyl-4-yl]acetic acid: a potential approach to reduce local gastrointestinal toxicity.
Halen PK; Chagti KK; Giridhar R; Yadav MR
Chem Biodivers; 2006 Nov; 3(11):1238-48. PubMed ID: 17193237
[TBL] [Abstract][Full Text] [Related]
14. Product development studies of amino acid conjugate of Aceclofenac.
Singh AP; Ramadan WM; Dahiya R; Sarpal AS; Pathak K
Curr Drug Deliv; 2009 Apr; 6(2):208-16. PubMed ID: 19450228
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization, and biological evaluation of novel diclofenac prodrugs.
Bandgar BP; Sarangdhar RJ; Ahamed FA; Viswakarma S
J Med Chem; 2011 Mar; 54(5):1202-10. PubMed ID: 21250699
[TBL] [Abstract][Full Text] [Related]
16. Polyacrylamide-grafted-alginate-based pH-sensitive hydrogel beads for delivery of ketoprofen to the intestine: in vitro and in vivo evaluation.
Kulkarni RV; Sa B
J Biomater Sci Polym Ed; 2009; 20(2):235-51. PubMed ID: 19154672
[TBL] [Abstract][Full Text] [Related]
17. Alkyl ester prodrugs for improved topical delivery of ibuprofen.
Bansal AK; Khar RK; Dubey R; Sharma AK
Indian J Exp Biol; 2001 Mar; 39(3):280-3. PubMed ID: 11495290
[TBL] [Abstract][Full Text] [Related]
18. Formulation of an aqueous injection of flurbiprofen.
Gupta GD; Jain S; Jain NK
Pharmazie; 1997 Sep; 52(9):709-12. PubMed ID: 9347572
[TBL] [Abstract][Full Text] [Related]
19. What should be considered on design of a colon-specific prodrug?
Jung Y; Kim YM
Expert Opin Drug Deliv; 2010 Feb; 7(2):245-58. PubMed ID: 20095945
[TBL] [Abstract][Full Text] [Related]
20. Ketorolac amide prodrugs for transdermal delivery: stability and in vitro rat skin permeation studies.
Kim BY; Doh HJ; Le TN; Cho WJ; Yong CS; Choi HG; Kim JS; Lee CH; Kim DD
Int J Pharm; 2005 Apr; 293(1-2):193-202. PubMed ID: 15778057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
